Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1

Immunity

Volumn 13, Issue 6, 2000, Pages 805-815

  Diehl, Sean ^a   Anguita, Juan ^b   Hoffmeyer, Angelika ^c   Zapton, Tyler ^a   Ihle, James N ^c   Fikrig, Erol ^b   Rincón, Mercedes ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HELPER CELL; IMMUNOREGULATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 0034502224     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)00078-9     Document Type: Article

References (56)

1. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
2. Suppressors of cytokine signaling (SOCS): Negative regulators of signal transduction
3. Effect of anti-interleukin 12 treatment on murine Lyme borreliosis
4. Borrelia burgdorferi-infected interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis
5. The IFN gamma receptor: A paradigm for cytokine receptor signaling
6. 4+ T cells in vitro is largely dependent on exogenous cytokines
7. Cellular responses to interferon-γ
8. A direct role for IFN-gamma in regulation of Th1 cell development
9. 4+ T cell responses: The alternative approaches
10. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression
11. Tissue-specific targeting of cytokine unresponsiveness in transgenic mice
12. A new protein containing an SH2 domain that inhibits JAK kinases
13. Cutting edge: Differentiation of antitumor CTL in vivo requires host expression of Stat1
14. 4+ T cells through IL-12 produced by Listeria-induced macrophages
15. Immune response in mice that lack the interferon-gamma receptor
16. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF
17. 4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor
18. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice
19. Impaired immune and acute-phase responses in interleukin-6-deficient mice
20. Role of IL-6 in directing the initial immune response to schistosome eggs
21. Jaks and STATs: Biological implications
22. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction
23. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
24. T helper phenotype and genetic susceptibility in experimental Lyme disease
25. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis
26. Functional role of type I and type II interferons in antiviral defense
27. T lymphocyte differentiation in the periphery
28. Signaling and transcription in T helper development
29. Structure and function of a new STAT-induced STAT inhibitor
30. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
31. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor
32. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes
33. 4+ T cells
34. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis
35. 4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans
36. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
37. IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses
38. Rapid detection of octamer binding proteins with 'mini'-extracts prepared from a small number of cells
39. 4+ T cells from T cell receptor transgenic mice
40. 4+ T cells to enhance priming for IFNγ production and diminish IL-4 inhibition of such priming
41. A family of cytokine-inducible inhibitors of signalling
42. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
43. Who does the polarizing?
44. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response
45. IL-6 rescues resting mouse T cells from apoptosis
46. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling
47. Interleukin-12: A cytckine at the interface of inflammation and immunity
48. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1
49. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
50. 4+ T cells is sufficient to mediate T helper cell type I development
51. Roles of IFNγ and IFNα in IL-12-induced T helper cell-1 development
52. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system
53. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
54. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain
55. 4+ T cells to Th1 cells requires MAP kinase JNK2
56. 4+ T cells: Evidence for two distinct pathways for promoter activation